ulixertinib   Click here for help

GtoPdb Ligand ID: 9210

Synonyms: BVD-523 | VRT-752271
PDB Ligand
Compound class: Synthetic organic
Comment: Ulixertinib is an orally available, ATP-competitive inhibitor of the serine/threonine kinases extracellular signal-regulated kinase (ERK) 1 (MAPK3) and 2 (MAPK1), being investigated for anticancer activity in solid tumours and hematological malignancies carrying mutations in the MAPK signaling pathway, which renders them highly reliant on ERK for survival and growth. It is being developed by BioMed Valley Discoveries. This is one of the compounds claimed in patent WO2005113541 [1], where it is identified as I-9.
The INN record specifies the (1S) stereoisomer as ulixertinib.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 4
Rotatable bonds 8
Topological polar surface area 90.04
Molecular weight 432.11
XLogP 4.45
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC(c1cccc(c1)Cl)NC(=O)c1[nH]cc(c1)c1cc(ncc1Cl)NC(C)C
Isomeric SMILES OC[C@H](c1cccc(c1)Cl)NC(=O)c1[nH]cc(c1)c1cc(ncc1Cl)NC(C)C
InChI InChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1
InChI Key KSERXGMCDHOLSS-LJQANCHMSA-N
Bioactivity Comments
Note that the image of BVD-523 presented in [2], does not specify stereochemistry, so it is unclear which isomer the data maps to.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
mitogen-activated protein kinase 3 Hs Inhibitor Inhibition >9.5 pIC50 - 2
pIC50 >9.5 (IC50 <3x10-10 M) [2]
Description: Biochemical assay determination
mitogen-activated protein kinase 1 Hs Inhibitor Inhibition >9.5 pIC50 - 2
pIC50 >9.5 (IC50 <3x10-10 M) [2]
Description: Biochemical assay determination